跳至主要内容
临床试验/NCT04171661
NCT04171661进行中(未招募)早期 1 期

SASS 3: Self-Assembled Skin Substitute (SASS) for the Treatment of Epidermolysis Bullosa

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2019年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
进行中(未招募)
发起方
入组人数
1
试验地点
1
主要终点
Percent reduction in wound surface area

研究概览

简要总结

Single patient study. Patient diagnosed with dystrophic epidermolysis bullosa presenting chronic open wounds that are not responding to dressings, topical preparations (antimicrobials, antibiotics) and systemic agents (anti-inflammatory antibacterials). The Self-Assembled Skin Substitutes will be used to cover wounds.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • This clinical trial was custom designed for one patient

排除标准

  • 未提供

研究组 & 干预措施

SASS

Experimental

SASS applied on chronic skin wounds as skin graft

干预措施: SASS (Biological)

结局指标

主要结局

Percent reduction in wound surface area

时间窗: 2 weeks

Clinical assessment

次要结局

  • Changes in pain scores(3 years)
  • Graft failure(2 weeks)
  • Time (in weeks) to 50% reduction in the surface area of the wounds;(3 years)
  • Number of subsequent re-transplantation(3 years)
  • Time (in weeks) to complete healing(3 years)
  • Changes in itch scores where 0 is none and 10 the worst itch(3 years)

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验